These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28257802)

  • 1. Assessment of influenza A neuraminidase (subtype N1) potency by ELISA.
    Wan H; Sultana I; Couzens LK; Mindaye S; Eichelberger MC
    J Virol Methods; 2017 Jun; 244():23-28. PubMed ID: 28257802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Efficacy of Monoclonal Antibodies That Bind to Different Epitopes of the 2009 Pandemic H1N1 Influenza Virus Neuraminidase.
    Jiang L; Fantoni G; Couzens L; Gao J; Plant E; Ye Z; Eichelberger MC; Wan H
    J Virol; 2016 Jan; 90(1):117-28. PubMed ID: 26468531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive and specific ELISA immunocapture assay for rapid quantitation of influenza A/H3N2 neuraminidase protein.
    Gerentes L; Kessler N; Aymard M
    J Virol Methods; 1998 Aug; 73(2):185-95. PubMed ID: 9766889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies.
    Ho HT; Qian HL; He F; Meng T; Szyporta M; Prabhu N; Prabakaran M; Chan KP; Kwang J
    Clin Vaccine Immunol; 2009 May; 16(5):726-32. PubMed ID: 19321691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of neuraminidase in inactivated influenza vaccines.
    Sultana I; Yang K; Getie-Kebtie M; Couzens L; Markoff L; Alterman M; Eichelberger MC
    Vaccine; 2014 Apr; 32(19):2225-30. PubMed ID: 24613525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
    Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An influenza N1 neuraminidase-specific monoclonal antibody with broad neuraminidase inhibition activity against H5N1 HPAI viruses.
    Shoji Y; Chichester JA; Palmer GA; Farrance CE; Stevens R; Stewart M; Goldschmidt L; Deyde V; Gubareva L; Klimov A; Mett V; Yusibov V
    Hum Vaccin; 2011; 7 Suppl():199-204. PubMed ID: 21922687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of antineuraminidase antibodies in protection against influenza].
    Aymard M; Gerentes L; Kessler N
    Bull Acad Natl Med; 1998; 182(8):1723-36; discussion 1736-7. PubMed ID: 10188318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic drift originating from changes to the lateral surface of the neuraminidase head of influenza A virus.
    Yasuhara A; Yamayoshi S; Kiso M; Sakai-Tagawa Y; Koga M; Adachi E; Kikuchi T; Wang IH; Yamada S; Kawaoka Y
    Nat Microbiol; 2019 Jun; 4(6):1024-1034. PubMed ID: 30886361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of an avian influenza, neuraminidase subtype 1, indirect enzyme-linked immunosorbent assay for poultry using the differentiation of infected from vaccinated animals control strategy.
    Liu Y; Mundt E; Mundt A; Sylte M; Suarez DL; Swayne DE; García M
    Avian Dis; 2010 Mar; 54(1 Suppl):613-21. PubMed ID: 20521703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies.
    Prevato M; Cozzi R; Pezzicoli A; Taddei AR; Ferlenghi I; Nandi A; Montomoli E; Settembre EC; Bertholet S; Bonci A; Legay F
    PLoS One; 2015; 10(8):e0135383. PubMed ID: 26267900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
    Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G
    J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir.
    Sultana I; Gao J; Markoff L; Eichelberger MC
    Vaccine; 2011 Mar; 29(14):2601-6. PubMed ID: 21288802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus.
    Jiang H; Peng W; Qi J; Chai Y; Song H; Bi Y; Rijal P; Wang H; Oladejo BO; Liu J; Shi Y; Gao GF; Townsend AR; Wu Y
    mBio; 2020 Oct; 11(5):. PubMed ID: 33024040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin.
    Rajendran M; Nachbagauer R; Ermler ME; Bunduc P; Amanat F; Izikson R; Cox M; Palese P; Eichelberger M; Krammer F
    mBio; 2017 Mar; 8(2):. PubMed ID: 28325769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.